Fast-Track Drugs and Biologics, LLC was founded in 2003 in response to the rapid developmental needs for countermeasures to bioterrorism agents. Our first three projects involved the development of therapeutics for anthrax (anthrax vaccine), botulism (botulinum antitoxin), and toxic shock (broad spectrum therapeutic). However, our company founders have been developing drug and biological therapeutics for infectious diseases, cancer, and cardiovascular diseases in the pharmaceutical and biotechnology industries for over 20 years.
 

The types of products that our combined experience includes follows:

  • Gene Therapy – adenoviral and retroviral vectors, plasmids, vaccinia,
  • Recombinant biologically active peptides/proteins
    Cytokines
  • Monoclonal antibodies
  • Cell therapy – T cells, LAK cells, gene-modified T cells
  • Chemotherapeutic drugs
  • Psychoactive drugs
  • Anti-depressants
  • Vaccines – cell based, protein based, virus based, bacterial components, and adjuvants
  
 

Some of the disease indications for which we have expertise include:

  • Cancer – bladder, colorectal, lung, pancreatic, breast, lymphoma, melanoma, renal cell carcinoma
  • AIDS
  • Anthrax
  • Plague
  • Small Pox
  • Staphylococcal Enterotoxic shock
  • Botulism
  • Tularemia
  • Q-fever
  • Hypercholesterolemia
  • Ischemic Cardiovascular Disease
  • Cocaine addiction
  • Methamphetamine addiction